Investing.com -- aTyr Pharma (NASDAQ:ATYR) stock fell 80% after the company announced that its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis failed to meet its primary endpoint. The ...

Investing.com - Futures linked to Canada’s main stock exchange pointed higher on Monday, as investors looked ahead to key ...

Intel revealed in a filing on Monday that it has lowered its full-year 2025 adjusted operating expense target following the sale of a majority stake in Altera to private equity firm Silver Lake. The ...

China’s Ministry of Commerce announced Saturday it had opened an anti-dumping probe into certain American-made analog IC chips. Texas Instruments, Analog Devices, Broadcom (NASDAQ:AVGO) and ON ...

VF Corporation (NYSE:VFC) stock rises after the apparel company announced it has entered into a definitive agreement to sell its Dickies brand to Bluestar Allianc ...

The S&P 500 slipped 0.05% to 6,584.29, while the Dow Jones Industrial Average fell 273.78 points, or 0.59%, to 45,834.22. All three benchmarks still ended the week higher, having closed at record ...

Our ability to scale IM8 to nearly $100 million in ARR within a year, while maintaining a strong $90 million cash and Bitcoin position, underscores the strength of our model,” Yeung told Investing.com ...

Intel (NASDAQ:INTC) stock gained 0.4% despite the chipmaker lowering its full-year 2025 adjusted operating expense target to $16.8 billion, from $17 billion earlier, to reflect the deconsolidation of ...

This marks Monte Rosa’s second collaboration with Novartis, following their October 2024 agreement for VAV1 degraders including MRT-6160. The new partnership will leverage Monte Rosa’s proprietary ...